The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Pimotab 15 mg chewable tablets for dogs

CP-Pharma Handelsgesellschaft mbHVPA10810/018/005

Main Information

Trade NamePimotab 15 mg chewable tablets for dogs
Active SubstancesPimobendan
Dosage FormChewable tablet
Licence HolderCP-Pharma Handelsgesellschaft mbH
License Holder AddressOstlandring 13
31303 Burgdorf
Licence NumberVPA10810/018/005

Group Information

ATC CodeQC01CE90 pimobendan
Therapeutic ClassCardiovascular


License statusAuthorised
Licence Issued17/07/2020
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back